-
Mashup Score: 4RxPR: The First Public Relations and Business Development Agency Dedicated to Pharmacy Launches January 30, 2025 - 1 month(s) ago
First podcast about the profession of pharmacy builds 70K+ listener market and network to expand client’s brands, stories, and connections to pharmacy leaders.
Source: www.newswire.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Beta Bionics Announces Closing of a $60 Million Series E Financing - 4 month(s) ago
Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, announces the successful closing of a $60 mi …
Source: www.newswire.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 4Cancer centers launch Cancer AI Alliance to unlock discoveries, transform care using cancer data and applied AI - 5 month(s) ago
AWS, Deloitte, Microsoft and NVIDIA bring the latest in AI technology, coordination, and compute to the alliance and back with initial funding
Source: www.newswire.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 16The Transmitter Partners With World Wide Neuro and Brain Inspired, Building on Mission to Inform, Connect Neuroscience Community - 6 month(s) ago
The Transmitter, a leading neuroscience publication, has partnered with World Wide Neuro and Brain Inspired to further its commitment to supportin …
Source: www.newswire.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0May Revision: Multi-Year Continuous Medi-Cal Coverage for Young Children Not Funded - 10 month(s) ago
Tens of Thousands of California Children’s Medi-Cal Coverage Not Preserved
Source: www.newswire.comCategories: General Medicine News, PediatricsTweet
-
Mashup Score: 3ASTCT Supports the FDA’s Approval of Earlier Use of CAR T-Cell Therapy for Multiple Myeloma - 11 month(s) ago
The Food and Drug Administration approves CAR T-Cell therapy Abecma as a second-line treatment and the CAR T-Cell therapy Carvykti as a third-line treatment for multiple myeloma.
Source: www.newswire.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 9ASTCT Supports the FDA’s Approval of Earlier Use of CAR T-Cell Therapy for Multiple Myeloma - 11 month(s) ago
The Food and Drug Administration approves CAR T-Cell therapy Abecma as a second-line treatment and the CAR T-Cell therapy Carvykti as a third-line treatment for multiple myeloma.
Source: www.newswire.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4The Centers for Medicare & Medicaid Services Revise National Coverage Determination for Stem Cell Transplantation - 12 month(s) ago
The Centers for Medicare & Medicaid Services revise the National Coverage Determination of allogeneic hematopoietic stem cell transplantation (HSCT) for individuals with myelodysplastic syndromes (MDS) based on requests from ASH, ASTCT, NMDP, and CIBMTR.
Source: www.newswire.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1ASCP Partners With the Lamy Center at the University of Maryland School of Pharmacy to Spread the Adoption of Age-Friendly Health Systems - 1 year(s) ago
As the older adult population continues to grow exponentially, the American Society of Consultant Pharmacists (ASCP) and The Peter Lamy Center on …
Source: www.newswire.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 12American Society for Transplantation and Cellular Therapy Awards Robin Roberts With the 2024 Public Service Award - 1 year(s) ago
The annual award honors Roberts’ special service to the patients and families that are served by the ASTCT community.
Source: www.newswire.comCategories: General Medicine News, Onc News and JournalsTweet
#RxPR: 1st Public Relations and Business Development Agency Dedicated solely to Pharmacy Launched today, January 30, 2025! https://t.co/pynXV0wc8K https://t.co/HsZ0gu7bSO